(Q21563424)
Statements
NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma (English)
Peter S Rabinovitch
Peter S
Rabinovitch
Patricia L Blount
Patricia L
Blount
Carissa A
Sanchez
Carissa A Sanchez
Patricia C Galipeau
Xiaohong Li
Carlo C Maley
Kamran Ayub
Thomas L Vaughan
Brian J Reid
1 February 2007
27 February 2007
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
2 references
2 references
2 references